Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products

In the twenty first century the interest in new anti-tuberculosis drugs based on natural products, specially against MDR (multidrug-resistant) and XDR (extensively drug resistant) tuberculosis (TB) is growing, as indicated by the increasing number of publications in this field. Some natural products, semisynthetic or synthetic compounds based on nature are in clinical studies and are the subject of this article.

In the twenty first century the interest in new anti-tuberculosis drugs based on natural products is growing, specially against MDR (multidrug-resistant) and XDR (extremely drug resistant) tuberculosis (TB), which can be noted by the increasing number of important publications in this field. In this context, some natural products, semisynthetic or synthetic compounds based on nature are in clinical studies, which will be highlighted in this article.Figure optionsDownload as PowerPoint slide